We publish the test before we sell the vial.

Why we started

The research-peptide market runs on trust, and most of it is misplaced. Vendors post a single certificate and reuse it for years, or post none at all. A researcher ordering a compound has almost no way to know what is actually in the vial.

We built Peptide Confidential to remove the guesswork. The model is that a production lot is analysed and its result — pass or fail — is published on the public ledger before a vial from that lot is offered for supply. That is enforced by the database rather than by policy: a lot cannot be released without its certificate, its purity, its test date, the laboratory and the method behind it.

Nothing above describes work that has not been done. The ledger carries every lot that has been tested and every certificate that has been issued — if it is not there, it has not happened.

That is the whole company: uncover, verify, inform. No claim we cannot back with a certificate — which today means no claim at all.